ResMed Price Prediction and Hype Density Breakdown

RMD -- USA Stock  

USD 108.68  0.70  0.64%

Macroaxis is not in business of monitoring ResMed headlines and social sentiment data; there are plenty of companies out there that do it quite successfully. However, we do analyze noise-free headlines and recent hype associated with ResMed brand which may create opportunities for some arbitrage if properly timed. With ResMed hype-based prediction module you can estimate the value of ResMed from the prospective of ResMed response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on ResMed over a specific investment horizon. Additionally take a look at ResMed Basic Forecasting Models to cross-verify your projections.
 Time Horizon     30 Days    Login   to change

ResMed After-Hype Price Density Analysis

 Next price density 
Expected price to next headline

ResMed Estimiated After-Hype Price Volatility

July 18, 2018
Current Value
After-hype Price
Target Odds
ResMed is not too risky asset. Analysis and calculation of next after-hype price of ResMed is based on 1 month time horizon.

ResMed Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.11% 1.05% 0.10%  0.03% 5 Events / Month6 Events / MonthIn about 5 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

ResMed Hype Timeline

On 18 of July ResMed is traded for 108.68. This company has historical hype elasticity of 0.1 and average elasticity to hype of competition of 0.03. ResMed is estimated to increase in value after the next headline with price going to jump to 109.51. The average volatility of media hype impact on the company stock price is about 116.67%. The price escalation on the next news is projected to be 0.12% where as daily expected return is at this time at 0.11%. The volatility of related hype on ResMed is about 434.78% with expected price after next announcement by competition of 108.71. The company reported last year revenue of 2.27 B. Total Income to common stockholders was 307.39 M with profit before taxes, overhead, and interest of 1.2 B. Considering 30-days investment horizon, the next estimated press release will be in about 5 days.
Additionally take a look at ResMed Basic Forecasting Models to cross-verify your projections.

ResMed Related Hype Analysis

At Risk
Ekso Bionics Holdings 0.14 3 per month 0.00 (0.0442)  3.77 (3.33)  16.81 
Endologix(0.17) 3 per month 0.00 (0.37)  1.91 (3.79)  12.07 
Baxter International 0.21 6 per month 0.00 (0.20)  1.00 (1.13)  2.75 
Becton Dickinson and Company 1.35 4 per month 0.11  0.18  1.87 (1.17)  3.19 
Bovie Medical Corporation(0.08) 4 per month 1.79  0.37  6.22 (3.18)  14.04 
Cantel Medical Corp 0.00 0 per month 0.00 (0.19)  2.72 (2.24)  7.63 
The Cooper Companies 0.04 5 per month 0.90  0.0373  1.39 (1.36)  3.29 
Daxor Corporation 0.14 2 per month 0.00 (0.22)  4.13 (3.56)  8.19 
Haemonetics Corporation 0.60 4 per month 1.77  0.09  2.72 (3.75)  6.72 
Hill Rom Holdings 0.18 5 per month 0.75  0.0188  1.52 (1.72)  2.35 

Investors are also interested in

Purchased over 100 shares
Active few hours ago
Purchased over 300 shares
Active few hours ago
Additionally take a look at ResMed Basic Forecasting Models to cross-verify your projections. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.